This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
H Peltola . Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews 2000; 13: 302–317.
PL Zuber , Sustaining GAVI-supported vaccine introductions in resource-poor countries. Vaccine 2011; 29: 3149–3154.
J Ward , Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group. New England Journal of Medicine 1990; 323: 1393–1401.
J Clemens , Evaluating new vaccines for developing countries. Efficacy or effectiveness? Journal of American Medical Association 1996; 275: 390–397.
A Clark , C Sanderson . Timing of children's vaccinations in 45 low-income and middle income countries: an analysis of survey data. Lancet
2009; 373: 1543–1549.
SP Fitzwater ,
Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries. Human Vaccines
2010; 6: 810–818.
CO Obonyo , J Lau . Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. European Journal of Clinical Microbiology and Infectious Diseases
2006; 25: 90–97.
A Liberati , The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009; 6: e1000100.
K Mulholland , Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191–1197.
JJ Deeks , DG Altman , MJ Bradburn . Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: M Egger , GD Smith , DG Altman , eds. Systematic Reviews in Health Care Meta-analysis in Context: BMJ Books, 2001.
Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa. Expert Review Vaccines
2009; 8: 91–102.
BD Gessner ,
Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet
2005; 365: 43–52.
AH Baqui ,
Effectiveness of Haemophilus influenzae type b conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Paediatric Infectious Disease Journal
2007; 26: 565–571.
JI Ward ,
Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. Journal of Infectious Diseases
1986; 153: 17–26.
R Singleton , The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics 2006; 118: e421–429.
KD Cowgill ,
Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. Journal of American Medical Association
2006; 296: 671–678.
R Lagos ,
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet
1998; 351: 1472–1476.
SA Madhi ,
Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatric Infectious Disease Journal
2002; 21: 315–321.
P Daza , The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 2006; 24: 6232–6239.
A CC von Gottberg ,
Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003–2009. Vaccine
2012; 30: 565–.71
J McVernon , Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. British Medical Journal 2004; 329: 655–658.
SB Black , Efficacy in infancy of oligosaccharide conjugate Haemophilus influenza type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatric Infectious Disease Journal 1991; 10: 97–104.
R Booy , Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994; 344: 362–366.
R Lagos , Large scale, postlicensure, selective vaccination of Chilean infants with PRPT conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatric Infectious Disease Journal 1996; 15: 216–222.